Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZuChem is a biotechnology company that specializes in the development of proprietary bioprocesses for the manufacture of unique carbohydrates and glycochemicals. The company utilizes a combination of biocatalysis and microbial whole-cell fermentation to produce high-value ingredients for the food, pharmaceutical, and specialty chemical industries. Its product portfolio includes alternative sweeteners like xylitol and mannitol, as well as rare sugars and pharmaceutical intermediates used in the synthesis of antibiotics and antiviral drugs. Headquartered in Chicago with research facilities in Peoria, Illinois, ZuChem focuses on 'green' and sustainable manufacturing methods to replace traditional chemical synthesis. The company has established significant partnerships, including a joint venture for large-scale xylitol production. In 2020, the company transitioned its rare sugars business to the Midwest Bioprocessing Center to focus on its core fermentation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZuChem.